49
Views
13
CrossRef citations to date
0
Altmetric
Original Article

What is Ineffective Erythropoiesis in Myelodysplastic Syndromes?

Pages 243-247 | Received 30 Jul 1994, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Craig Dorrell, Katsuto Takenaka, Mark D. Minden, Robert G. Hawley & John E. Dick. (2004) Hematopoietic Cell Fate and the Initiation of Leukemic Properties in Primitive Primary Human Cells Are Influenced by Ras Activity and Farnesyltransferase Inhibition. Molecular and Cellular Biology 24:16, pages 6993-7002.
Read now
Dominic J. Culligan. (1998) Pathogenetic Aspects of Myelodysplastic Syndromes. Hematology 3:2, pages 119-142.
Read now

Articles from other publishers (11)

Hongxia YanYaomei WangXiaoli QuJie LiJohn HaleYumin Huang, Chao AnJulien PapoinXinhua GuoLixiang ChenQiaozhen KangWei LiVincent P. Schulz, Patrick G. Gallagher, Christopher D. HillyerNarla MohandasXiuli An. (2017) Distinct roles for TET family proteins in regulating human erythropoiesis. Blood 129:14, pages 2002-2012.
Crossref
Rajasekhar N. V. S. Suragani, Sharon M. Cawley, Robert Li, Samantha Wallner, Mark J. Alexander, Aaron W. Mulivor, Sara Gardenghi, Stefano Rivella, Asya V. Grinberg, R. Scott Pearsall & Ravindra Kumar. (2014) Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia. Blood 123:25, pages 3864-3872.
Crossref
Rajasekhar N V S Suragani, Samuel M Cadena, Sharon M Cawley, Dianne Sako, Dianne Mitchell, Robert Li, Monique V Davies, Mark J Alexander, Matthew Devine, Kenneth S Loveday, Kathryn W Underwood, Asya V Grinberg, John D Quisel, Rajesh Chopra, R Scott Pearsall, Jasbir Seehra & Ravindra Kumar. (2014) Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis. Nature Medicine 20:4, pages 408-414.
Crossref
Xiao Li, Lingyun Wu, Shaoxu Ying, Chunkang Chang & Quan Pu. (2008) Clonality investigation of morphologically dysplastic hematopoietic cells in myelodysplastic syndrome marrows. International Journal of Hematology 87:2, pages 176-183.
Crossref
James C Barton. (2007) Optimal Management Strategies for Chronic Iron Overload. Drugs 67:5, pages 685-700.
Crossref
A. Torres Gomez, J. Casaño, J. Sánchez, E. Madrigal, F. Blanco & M. A. Alvarez. (2003) Utility of reticulocyte maturation parameters in the differential diagnosis of macrocytic anemias. Clinical & Laboratory Haematology 25:5, pages 283-288.
Crossref
WK Hofmann, WJ Kell, P Fenaux, S Castaigne, A Ganser, C Chomienne, R Burnett, C Kowal, D Hoelzer & AK Burnett. (2000) Oral 9-cis retinoic acid (Alitretinoin) in the treatment of myelodysplastic syndromes: results from a pilot study. Leukemia 14:9, pages 1583-1588.
Crossref
T. E. Manakova, L. P. Gerasimova, N. V. Tsvetaeva & K. S. Momotyuk. (2000) Functional disturbances in hemopoietic microenvironment in various forms of myelodysplastic syndrome. Bulletin of Experimental Biology and Medicine 130:3, pages 832-834.
Crossref
Robert Hast, Maria Eriksson, Susanne Widell, Ingrid Arvidsson & Per Bemell. (1999) Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes. Leukemia Research 23:6, pages 579-584.
Crossref
Saleem Dar, Suneel Mundle, Tanja Andric, Huma Qawi, Vilasini Shetty, Samina Reza, B. Yifwayimare Mativi, Krishnan Allampallam, Ambereen Ali, Parameswaren Venugopal, Sefer Gezer, LaTanya Broady‐Robinson, John Cartlidge, Margaret Showel, Seema Hussaini, Deborah Ragasa, Irfan Ali, Ambreen Chaudhry, Samina Waggoner, Laurie Lisak, Ray‐Win Huang & Azra Raza. (2009) Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis. European Journal of Haematology 62:2, pages 90-94.
Crossref
A. Mijović & G.J. Mufti. (1998) The myelodysplastic syndromes: towards a functional classification. Blood Reviews 12:2, pages 73-83.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.